Weiss Ratings Reaffirms “Hold (C-)” Rating for Integer (NYSE:ITGR)

Integer (NYSE:ITGR)‘s stock had its “hold (c-)” rating reiterated by Weiss Ratings in a research note issued on Friday,Weiss Ratings reports.

A number of other analysts have also recently commented on the company. Bank of America cut Integer from a “buy” rating to a “neutral” rating and set a $87.00 price target for the company. in a research note on Friday, October 24th. Piper Sandler lowered their price target on Integer from $155.00 to $82.00 and set an “overweight” rating for the company in a research note on Friday, October 24th. KeyCorp lowered their price target on Integer from $145.00 to $133.00 and set an “overweight” rating for the company in a research note on Tuesday, October 21st. Wells Fargo & Company reissued an “equal weight” rating and set a $80.00 target price (down from $132.00) on shares of Integer in a research note on Friday, October 24th. Finally, Wall Street Zen cut Integer from a “buy” rating to a “hold” rating in a research note on Saturday, October 25th. Four analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $97.75.

Integer Stock Performance

Shares of ITGR stock opened at $64.59 on Friday. The company has a debt-to-equity ratio of 0.70, a current ratio of 3.71 and a quick ratio of 2.45. The stock has a market cap of $2.26 billion, a PE ratio of 27.02, a price-to-earnings-growth ratio of 0.60 and a beta of 0.97. The stock has a 50-day moving average of $99.51 and a 200-day moving average of $110.70. Integer has a one year low of $62.00 and a one year high of $146.36.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, October 23rd. The medical equipment provider reported $1.79 EPS for the quarter, beating analysts’ consensus estimates of $1.68 by $0.11. The company had revenue of $467.69 million during the quarter, compared to analysts’ expectations of $466.45 million. Integer had a return on equity of 12.84% and a net margin of 4.75%.Integer’s revenue was up 8.4% on a year-over-year basis. During the same period in the prior year, the business posted $1.43 EPS. Integer has set its FY 2025 guidance at 6.290-6.430 EPS. As a group, sell-side analysts expect that Integer will post 6.01 earnings per share for the current year.

Insider Transactions at Integer

In other Integer news, CEO Payman Khales bought 3,127 shares of the stock in a transaction that occurred on Thursday, October 30th. The stock was acquired at an average cost of $64.94 per share, with a total value of $203,067.38. Following the purchase, the chief executive officer owned 22,865 shares in the company, valued at $1,484,853.10. This trade represents a 15.84% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 2.16% of the company’s stock.

Hedge Funds Weigh In On Integer

Several hedge funds have recently made changes to their positions in the business. State Street Corp grew its stake in shares of Integer by 1.0% during the 2nd quarter. State Street Corp now owns 1,326,050 shares of the medical equipment provider’s stock worth $163,064,000 after acquiring an additional 13,540 shares in the last quarter. Viking Global Investors LP grew its stake in shares of Integer by 9.1% during the 2nd quarter. Viking Global Investors LP now owns 1,283,965 shares of the medical equipment provider’s stock worth $157,889,000 after acquiring an additional 106,692 shares in the last quarter. Alliancebernstein L.P. grew its stake in shares of Integer by 885.1% during the 2nd quarter. Alliancebernstein L.P. now owns 1,106,091 shares of the medical equipment provider’s stock worth $136,016,000 after acquiring an additional 993,810 shares in the last quarter. Franklin Resources Inc. grew its stake in shares of Integer by 11.5% during the 2nd quarter. Franklin Resources Inc. now owns 907,232 shares of the medical equipment provider’s stock worth $111,562,000 after acquiring an additional 93,294 shares in the last quarter. Finally, Geode Capital Management LLC grew its stake in shares of Integer by 3.9% during the 2nd quarter. Geode Capital Management LLC now owns 819,089 shares of the medical equipment provider’s stock worth $100,736,000 after acquiring an additional 31,026 shares in the last quarter. 99.29% of the stock is owned by institutional investors.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.